ロード中...
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
Soft tissue sarcomas of childhood are a group of heterogeneous tumors thought to be derived from mesenchymal stem cells. Surgical resection is effective only in about 50% of cases and resistance to conventional chemotherapy is often responsible for treatment failure. Therefore, investigations on nov...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3126730/ https://ncbi.nlm.nih.gov/pubmed/21609503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-9-63 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|